1. Home
  2. SPRY

SPRY

ARS Pharmaceuticals Inc.

Logo ARS Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Founded: 2015 Country:
United States
United States
Employees: 26 City: SAN DIEGO
Market Cap: 870.4M IPO Year: N/A
Target Price: $18.50 AVG Volume (30 days): 673.4K
Analyst Decision: Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.57 EPS Growth: N/A
52 Week Low/High: $2.55 - $11.27 Next Earning Date: 05-13-2024
Revenue: $30,000 Revenue Growth: -97.72%
Revenue Growth (this year): 14123.33% Revenue Growth (next year): 1580.62%

Share on Social Networks: